Clinical Trial Update: Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study is comparing Bictegravir/Lenacapavir to current therapy in adults with HIV-1 infection who are well controlled on a complex regimen; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bictegravir (bictegravir)
• Lenacapavir (lenacapavir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING